Search clinical trials for: Eravacycline (TP-434)

Total 718 results

Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

End Stage Renal Disease
Tetraphase Pharmaceuticals, Inc.

Completed

A Safety and PK Study of IV Eravacycline

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.
Department of Health and Human Services

Completed

Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women (BAL)

Normal Drug Tolerance

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects

Impaired Hepatic Function

United States
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections (IGNITE4)

Complicated Appendicitis | Complicated Intra-abdominal Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Lithuania, Hungary, Latvia, Georgia, Czechia
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections (IGNITE1)

Complicated Intra-abdominal Infections

United States, France, Ukraine, Argentina, Bulgaria, Romania, South Africa, Germany, Estonia, Russian Federation, Lithuania, Czechia, Latvia
Tetraphase Pharmaceuticals, Inc.

Completed

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Complicated Intra-abdominal Infection

United States, Latvia, Lithuania, Romania, India, Bulgaria
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

cUTI

United States, Latvia, Poland, Czechia, Romania, Ukraine, Russian Federation, Georgia, Colombia, Bulgaria, Estonia, Greece, Hungary, Israel, Italy, Mexico, Moldova, Republic of, South Africa
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections (IGNITE3)

Complicated Urinary Tract Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Hungary, Austria, Slovakia, Latvia, Moldova, Republic of, Georgia
Sichuan Provincial People's Hospital

Not yet recruiting

Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS Infection

Immune Dysregulation Disorder
West Virginia University

Recruiting

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Neutropenia | Hematological Malignancy

United States
Emory University
Cooperative for Assistance and Relief Everywhere, Inc. (CARE)

Completed

Preventing Early Child Marriage in Nepal

Child Marriage

Nepal
Tarsus Pharmaceuticals, Inc.

Completed

Study to Evaluate the Food Effect of TP-05 in Healthy Participants

Healthy

United States
International Centre for Diarrhoeal Disease Research...
CARE Bangladesh; Gram Bikash Kendra (GBK); CARE USA

Recruiting

Evaluation of Tipping Point

Child Marriage

Bangladesh
Fujian Medical University Union Hospital

Recruiting

Eravacycline Combination Therapy for MRAB

Pneumonia, Bacterial | Pulmonary Infection | Acinetobacter Baumannii

China
Sumitomo Pharma America, Inc.

Completed

Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654

Healthy

United States
Sumitomo Pharma America, Inc.

Terminated

Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors

Sarcoma | Ewing Sarcoma | Advanced Solid Tumors | Synovial Sarcoma | Dedifferentiated Liposarcoma

United States
St George's, University of London
Neovii Biotech

Withdrawn

Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy (TEETPIM)

Mitochondrial Diseases | Inborn Errors of Metabolism | Metabolic Disease
Oncternal Therapeutics, Inc

Recruiting

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Metastatic Castration-resistant Prostate Cancer

United States, United Kingdom
Sumitomo Pharma America, Inc.

Recruiting

A Study of Oral TP-3654 in Patients With Myelofibrosis

Myelofibrosis

United States, Japan, Australia
Sumitomo Pharma America, Inc.

Completed

Study of TP-3654 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Aljazeera Hospital
Cairo University

Completed

Evaluation of TP US in Women With Prolapse

Prolapse

Egypt
Universitat Jaume I

Not yet recruiting

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

Anxiety Disorders | Depressive Disorders
Sumitomo Pharma America, Inc.

Terminated

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLL

United States
Tarsus Pharmaceuticals, Inc.

Active, not recruiting

A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Healthy Volunteer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)

Meibomian Gland Dysfunction | Blepharitis | Demodex Infestation

United States
Technophage, SA
VectorB2B

Not yet recruiting

Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia (RECOVER)

Pneumonia, Ventilator-Associated

France
Sumitomo Pharma America, Inc.

Terminated

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Anemia in Myelodysplastic Syndromes

United States
Sumitomo Pharma America, Inc.

Active, not recruiting

Phase 1 Study of Oral TP-1454

Advanced Solid Tumor | Anal Cancer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-2)

Blepharitis

United States
National Taiwan University Hospital

Unknown

Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer

Esophageal Cancer

Taiwan
Tarsus Pharmaceuticals, Inc.

Completed

A Pharmacokinetic Study of TP-05 in Healthy Subjects

Healthy

United States
Hospital El Cruce

Completed

Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2 (VILIVORTEX)

ARDS | Ventilator-Induced Lung Injury | Mechanical Ventilation Complication

Argentina
National Institute of Diabetes and Digestive and...

Completed

North American Study for the Treatment of Refractory Ascites (NASTRA)

Liver Cirrhosis | Ascites

United States, Canada
Aljazeera Hospital
Kasr El Aini Hospital

Unknown

Evaluation of Labour Progress by PC Angle

Labour

Egypt
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated Melanoma

United States
Hospital El Cruce

Completed

The Role of Morphological Phenotype in ARDS (MPARDS)

Respiratory Distress Syndrome, Adult

Argentina
MedMira Laboratories Inc.
Public Health Agency of Canada (PHAC)

Recruiting

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

Syphilis | Syphilis Infection | Early Syphilis, Symptomatic

Canada
Hebei Medical University Fourth Hospital

Not yet recruiting

Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma
Technophage, SA
VectorB2B

Recruiting

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

Diabetic Foot Infection

United States, India
University of Alabama at Birmingham

Completed

Gait Training Combined With Behavioral Strategies for People With Stroke

Stroke | Gait, Hemiplegic | Behavior and Behavior Mechanisms

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

Pneumonia

United States
Dilara Aydin Tozlu

Not yet recruiting

The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study

Sudden Infant Death
Tianjin Medical University Cancer Institute and...

Recruiting

Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | Neoadjuvant Chemotherapy

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Glioblastoma Multiforme
Technophage, SA
VectorB2B

Completed

Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (REVERSE)

Diabetic Foot Ulcer | Staphylococcus Aureus Infection | Pseudomonas Aeruginosa Infection | Acinetobacter Infection

Israel
Tarsus Pharmaceuticals, Inc.

Completed

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

Blepharitis

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

Bacterial Infections

United States

Search clinical trials for: Eravacycline (TP-434)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations